Tuesday, September 20, 2016 9:00 PM EDT
Biotechnology is becoming hot again. It is no secret that we are bullish on biotech.
Biotech companies have a track record of being very volatile, similar to gold stocks for instance. In an uptrend, they can easily rise multifolds. When biotech sold off last year, however, biotech companies truly collapsed in a matter of 3 to 6 months.
An important indicator of a company’s health is its ability to stand strong during a market correction.
One of the biotech companies which has done great since last year’s correction(s) is BioTime, symbol BTX. Quite some positive news hit the wires recently, including the news that USC neuroscientists announced historic news about BioTime’s (BTX) stem cell platform, as, for the first time, a quadriplegic patient with complete injury to the spinal cord has substantially recovered.
In an investor update, the CEO wrote: “News that was released this morning by the University of Southern California offers hope to patients suffering from severe spinal cord injury. A team of doctors at USC are evaluating the safety and efficacy of AST-OPC1 as a therapy for spinal cord injuries. As reported, a paralyzed patient in the study regained the use of his arms and hands after treatment with AST-OPC1 in April. Asterias announced that it expects to report its interim efficacy data on September 14, during the 55th Annual Scientific Meeting of the International Spinal Cord Society (ISCoS), which is being held in Vienna, Austria.”
Financially, the company is in good shape, given $20M loss on Dec 31st 2015, profits of $24M on June 30th and $27M in cash on June 30th. Moreover, chart-wise, BTX is engaging in a huge breakout.
BioTime has a top position on on our shortlist.
Disclaimer: InvestingHaven.com makes every effort to ensure that the information ...
more
Disclaimer: InvestingHaven.com makes every effort to ensure that the information provided is complete, correct, accurate and updated.In spite of these efforts, errors may occur in the information provided.If the information provided contains errors or if certain information is not available on or via the site, InvestingHaven.com will make every effort to rectify the situation as soon as possible. However, InvestingHaven.com cannot be held liable for direct or indirect damages resulting from the use of the information on this site. If you notice any errors in the information provided via the site, please contact the manager of the site.
Moreover, the views expressed in the articles (posts) on this website are the ones from the authors and are for information only. It is not intended as an offer, invitation, or solicitation to buy or sell any of any security or asset described. Nor the website manager nor the authors do accept any liability whatsoever for any direct or consequential loss arising from the use of their content. Please consult a qualified financial advisor before making investments. The information on this website and in the articles (posts) is believed to be reliable , but the authors do not make any representations as to its accuracy or completeness.
The content of the site (including links) may be adjusted, changed or expanded at any time without notice. InvestingHaven.com does not guarantee the proper functioning of the website and cannot be held liable in any way for the improper functioning or temporary (un)availability of the website or for any form of damage, direct or indirect, which may be the result of access to or use of the website.
InvestingHaven.com cannot be held liable under any circumstances by anyone, directly or indirectly, in any specific or other way, for damages resulting from the use of this site or any other site connected by means of links or hyperlinks, including, without limitation, any losses, interruptions of work, damage to programmes or other information on the computer system or to equipment, software or other items owned by the user.
less
How did you like this article? Let us know so we can better customize your reading experience.
